Shulin Li

11PUBLICATIONS
28CO-AUTHORS
Molecular targetsTumour immunologyCellular interactions (incl. adhesion, matrix, cell wall)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 06, 2025
Collagen-disrupting attIL12 TIL therapy boosts deep T cell infiltration via dual signaling activation and CCKAR reduction in sarcomas.

Jiemiao Hu, Harjeet Singh, Yining Jin

|Jun 21, 2022
Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma.

Qing Yang, Jiemiao Hu, Zhiliang Jia

Pageof 2